ClosedSuppliesEuropeanOnderhandeling zonder bekendmakingGreen

Voluntary transparency regarding the prior supply of ProQuad chickenpox vaccine

Name: Voluntary transparency regarding the prior supply of ProQuad chickenpox vaccine
Creator: Rijksinstituut voor Volksgezondheid en Milieu (RIVM)
Published: 2024-09-08
License: https://creativecommons.org/publicdomain/zero/1.0/

Rijksinstituut voor Volksgezondheid en Milieu (RIVM) · Onderhandeling zonder bekendmaking · 1 lots · 348240

0 of 6 core insights found

Measures presence, not accuracy · documents remain authoritative

ScopeAdvicePoints of attentionSuitability requirementsAward criteriaTimeline

Type

Supplies

33651600

Estimated value

Not published

To deadline

Ongoing

Knock-outs

n/a

exclusion grounds

Award basis

Best price-quality ratio

Assess manuallyconfidence low

Supplies ProQuad chickenpox vaccines with a supply contract for 2025, including an option for 5 tacit extensions of one year each.

Supplies · Onderhandeling zonder bekendmaking · European procedure

Sustainability countsEuropean

Contracting authority

Rijksinstituut voor Volksgezondheid en Milieu (RIVM)

Contract type

Supplies

Onderhandeling zonder bekendmaking

Estimated value

Estimate not published

Submission deadline

Ongoing

Scope

European

European procedure

Lots

1 lots

Main CPV code

33651600

Location

Netherlands

CharacteristicsCPV 33SuppliesEU tenderGreen / SPP

01What is being requested

Supplies ProQuad chickenpox vaccines with a supply contract for 2025, including an option for 5 tacit extensions of one year each.

Supply of Proquad vaccines Supply contract 2025 + option for 5 tacit extensions of 1 year each.

33651600Supplies

11—

02Exclusion grounds

Exclusion grounds — consult the ESPD

No specific exclusion grounds were extracted. In a European tender, the mandatory and discretionary grounds of art. 2.86/2.87 of the Dutch Procurement Act almost always apply — check the European Single Procurement Document (ESPD).

03Value in context

Estimate not published

The contracting authority did not publish an estimated value — common for a large share of contracts. The EU threshold for leveringen is € 221.000, for reference.

04Likely competitors

#Likely bidderFitWins

1GlaxoSmithKline B.V.SME756×

2Mediost B.V.SME7514×

3Vandeputte MedicalUnknown699×

4Genzyme Europe BVSME682×

5Glaxo SmithKline BVSME662×

6Almeva B.V.SME658×

05Legal themes that may be relevant here

Advies 59> Meervoudig onderhandse aanbestedingsprocedure met betrekking tot een opdracht voor de levering van postdiensten en bezorging. In Advies 222> Aanbesteding via een marktplaats. De Commissie bevestigt haar eerdere adviezen (waaronder 147) dat op een aanbestedende dienst d Advies 121> Nationale openbare aanbestedingsprocedure. Kan van inschrijvers gevraagd worden een opgave te doen van onvoorziene gebeurtenisse Advies 105> Europese openbare aanbestedingsprocedure met betrekking tot netwerkbeheer en levering van hardware. Is het in de nota van inlich Advies 53> Europese openbare procedure voor een overheidsopdracht tot het verrichten van diensten bestaande uit (dagelijks en periodiek) sc

06Frequently asked questions

What is the scope of the assignment regarding the supply of ProQuad?

The assignment concerns the supply of ProQuad chickenpox vaccines.

What is the duration of the supply contract for the ProQuad vaccines?

It concerns a supply contract for the year 2025, with the option for 5 tacit extensions of one year each.

Are there sustainability criteria applicable to this assignment?

Yes, sustainability criteria are applicable to this assignment.

Automatically compiled from the official tender data and documents.

07Estimated value versus the market

p25
€ 317K

median
€ 892K

p75
€ 3,3 mln

deze opdracht

Gegunde waarden in CPV 33 · leveringen n=528